4//SEC Filing
Nabiey Romin 4
Accession 0001809519-25-000152
CIK 0001809519other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 6:28 PM ET
Size
13.3 KB
Accession
0001809519-25-000152
Insider Transaction Report
Form 4
Nabiey Romin
Chief Accounting Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2025-12-08+10,200→ 167,692 total - Tax Payment
Class A Common Stock
2025-12-08$2.71/sh−3,650$9,892→ 164,042 total - Exercise/Conversion
Class A Common Stock
2025-12-08+2,232→ 166,274 total - Tax Payment
Class A Common Stock
2025-12-08$2.71/sh−799$2,165→ 165,475 total - Exercise/Conversion
Restricted Stock Unit
2025-12-08−10,200→ 30,603 total→ Class A Common Stock (10,200 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-12-08−2,232→ 20,091 total→ Class A Common Stock (2,232 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
- [F2]The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.
- [F3]The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.
Documents
Issuer
GoodRx Holdings, Inc.
CIK 0001809519
Entity typeother
Related Parties
1- filerCIK 0001924892
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 6:28 PM ET
- Size
- 13.3 KB